Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of Pemirolast in Healthy Subjects
NCT02517372Phase 1Completed
- Sponsor
- RSPR Pharma
- Start
- Oct 2014
- Primary completion
- Dec 2014
- Modality
- Small Molecules
01
Overview
Phase 1, open-label trial of pemirolast in asthma (3 arms), sponsored by RSPR Pharma. Primary endpoints: Number of patients with Adverse Events at Day 5, Results of physical examination at Day 5 and 2 more. Started Oct 2014; status: completed.
02
Drugs
pemirolast
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02517372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02517372.